Follow The Filings

RXO

Industrials, filed as RXO INC (COMMON STOCK), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 2 Owners
  • Max 0.1%
  • $2.2M
  • 1 new

In 2026 Q2 Polen Capital Management opened a position in RXO.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Mason Hawkins, Southeastern Asset Management). Not free-float ownership.

  1. Mason Hawkins 0.06%
  2. Polen Capital Management New 0.01%

Who owns RXO

Sorted by value, long equity only, as of 2026 Q2.

History
Mason Hawkins, Southeastern Asset Management 0.06% Hold 43,731 $1.2M History
Polen Capital Management 0.01% New 0.01% 37,400 $1M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by RXO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RXO insider trades
  • $7M bought by 5 insiders
  • $386K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. MFN Partners, LP 10% owner, +5 joint filers
    Buy
    $6.4M 532,276 shares at $12.00 +1.9% to stake
    Traded Feb 12 Filed Feb 17
  2. Troy A. Cooper Director
    Buy
    $88K 8,317 shares at $10.61 +3.1% to stake
    Traded Nov 20, 2025 Filed Nov 24, 2025
  3. Adrian Kingshott Director
    Buy
    $101K 9,350 shares at $10.75 +11% to stake
    Traded Nov 17, 2025 Filed Nov 19, 2025
  4. Jason S. Kerr Chief Accounting Officer
    Sale
    $386K 33,343 shares at $11.57 43% of stake
    Traded Nov 10, 2025 Filed Nov 12, 2025
  5. Thomas A Szlosek Director
    Buy
    $251K 20,308 shares at $12.37 +125% to stake
    Traded Nov 7, 2025 Filed Nov 12, 2025
  6. Andrew M. Wilkerson CEO
    Buy
    $149K 11,625 shares at $12.85
    Traded Nov 10, 2025 Filed Nov 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 20 option exercises, 16 share withholdings for taxes, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
SCHEDULE 13D —
8-K 1.01,8.01,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
8-K 5.07
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G/A —
8-K 1.01,2.03,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 7.01,9.01
10-K

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.93B $4.55B $5.74B
Net income $4M -$290M -$100M
Net margin * 0.1% -6.4% -1.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $0.796B $1.34B $1.32B
Total non-current assets $1.03B $2.08B $1.96B
Total assets $1.82B $3.41B $3.28B
Total current liabilities $0.682B $1.06B $1.04B
Total non-current liabilities $549M $737M $698M
Total equity $0.594B $1.61B $1.54B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $89M -$12M $51M
Cash from investing -$0.066B -$1.06B -$0.071B
Cash from financing -$0.117B $1.11B $0.001B
Net change in cash -$93M $30M -$17M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.